caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1720039126

Rodrigo ErlichM.D.

PRACTICEMED-TRANS CORPORATIONSee all providers at this practice →
Hematology-OncologyMason City, IAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Rodrigo Erlich's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 52 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
SHORE HEALTH SYSTEM, INC3547,455
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
1511,448
David Smith
Hematology-Oncology · Easton, MD
921,147
Kevin Gately
Diagnostic Radiology · Easton, MD
81370
EVANS, CHRISTIAN76380
SMITH, DAVID69348
SHORE HEALTH SYSTEM, INC67899
Melvin Rapelyea
Diagnostic Radiology · Cookeville, TN
67314
SAHMEL, REINHARDT63247
SMORZANIUK, EVA59369
DANNER, DAVID57216
BRIGHAM, STEPHEN54223
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
387
Unique beneficiaries
—
Total services
583
Distinct HCPCS
7
Medicare payment
$37K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 50 Hematology-Oncology providers in IA — below median (cohort median 1,234).
PRESCRIBING · PART D · 2024
Total Rx claims
1,715
Beneficiaries
—
Total drug cost
$1.7M
Distinct drugs
45
Brand share
21.0%
Top prescribed drugs
Anastrozole149 claims
Letrozole97 claims
Gabapentin96 claims
Hydroxyurea80 claims
Dexamethasone79 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.